170 related articles for article (PubMed ID: 2285303)
1. Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Sarić M; Grady RW
Antimicrob Agents Chemother; 1990 Sep; 34(9):1833-5. PubMed ID: 2285303
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Williams DE; Rosenberg C
Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.
Smith D; Davies S; Nelson M; Youle M; Gleeson J; Gazzard B
AIDS; 1990 Oct; 4(10):1019-21. PubMed ID: 2261116
[TBL] [Abstract][Full Text] [Related]
4. Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients.
Smith DE; Davies S; Smithson J; Harding I; Gazzard BG
AIDS; 1992 Dec; 6(12):1489-93. PubMed ID: 1492932
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.
Chin K; Merali S; Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137
[TBL] [Abstract][Full Text] [Related]
7. Treatment of infection due to Pneumocystis carinii.
Fishman JA
Antimicrob Agents Chemother; 1998 Jun; 42(6):1309-14. PubMed ID: 9624465
[No Abstract] [Full Text] [Related]
8. Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.
Merali S; Chin K; Grady RW; Clarkson AB
Antimicrob Agents Chemother; 1996 May; 40(5):1298-300. PubMed ID: 8723489
[TBL] [Abstract][Full Text] [Related]
9. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro.
Cushion MT; Stanforth D; Linke MJ; Walzer PD
Antimicrob Agents Chemother; 1985 Dec; 28(6):796-801. PubMed ID: 3936409
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. A prospective study among patients with the acquired immunodeficiency syndrome.
Golden JA; Sjoerdsma A; Santi DV
West J Med; 1984 Nov; 141(5):613-23. PubMed ID: 6440364
[TBL] [Abstract][Full Text] [Related]
11. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
[TBL] [Abstract][Full Text] [Related]
12. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.
Walzer PD; Kim CK; Foy J; Linke MJ; Cushion MT
Antimicrob Agents Chemother; 1988 Jun; 32(6):896-905. PubMed ID: 3137861
[TBL] [Abstract][Full Text] [Related]
13. Clinically achievable plasma deferoxamine concentrations eliminate Pneumocystis carinii trophozoites in a rat model.
Merali S; Chin K; Grady RW; Clarkson AB
J Eukaryot Microbiol; 1996; 43(5):52S. PubMed ID: 8822854
[No Abstract] [Full Text] [Related]
14. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
Boylan CJ; Current WL
Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
[TBL] [Abstract][Full Text] [Related]
16. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.
Merali S; Chin K; Grady RW; Weissberger L; Clarkson AB
Antimicrob Agents Chemother; 1995 Jul; 39(7):1442-4. PubMed ID: 7492082
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.
Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1994 Nov; 38(11):2545-52. PubMed ID: 7872745
[TBL] [Abstract][Full Text] [Related]
18. Eflornithine treatment of Pneumocystis carinii pneumonia in AIDS.
Gilman TM; Paulson YJ; Boylen CT; Heseltine PN; Sharma OP
JAMA; 1986 Oct 24-31; 256(16):2197-8. PubMed ID: 3093697
[No Abstract] [Full Text] [Related]
19. Action of deferoxamine against Pneumocystis carinii.
Clarkson AB; Turkel-Parrella D; Williams JH; Chen LC; Gordon T; Merali S
Antimicrob Agents Chemother; 2001 Dec; 45(12):3560-5. PubMed ID: 11709340
[TBL] [Abstract][Full Text] [Related]
20. Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia.
Merali S; Chin K; Del Angel L; Grady RW; Armstrong M; Clarkson AB
Antimicrob Agents Chemother; 1995 Sep; 39(9):2023-6. PubMed ID: 8540710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]